CPHI Milan Live: What matters more now?
Notas do episódio
Live from CPHI Milan, Molecule to Market and ramarketing bring together 11 senior leaders from across the global pharma outsourcing sector to tackle some of the industry's biggest trade-offs.
In this special episode, produced in partnership with ramarketing, host Raman Sehgal cuts through the usual industry talking points with a series of rapid-fire, either-or questions designed to uncover what leaders are really prioritizing, where opinions align, and where perspectives differ.
From balancing cost with flexibility to weighing technology against human expertise, we explore the decisions shaping the future of pharma services, what customers value most, and where the industry could be heading over the next five years.
Expect different perspectives, some tough choices, and plenty of food for thought from the people helping shape the future of pharma outsourcing.
Featuring insights from:
- Maja Pedersen, President and COO at Fujifilm Biotechnologies
- Hayley Crowe, Executive VP and General Manager of Global Life Sciences at Ecolab
- John Wichelt, VP/General Manager at Kindeva
- Henning Steinhagen, CEO at Symeres
- Campbell Bunce, Chief Scientific Officer at Abzena
- Patrick Kelley, Senior Director - Commercial at Pace Life Sciences
- Matt Peterson, Chief Strategy Officer at Quotient Sciences
- Joe Lipari, Director, Global Traceability Solutions at Systech
- Martin Meeson, CEO at Axplora
- Darren Hieber, VP of Alliance Partnerships at Ensera Pharma/Design
- Luke Guerrero, Co-Founder & Director of Operations at Digital CMC Consortium
Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Todos os episódios de Molecule to Market: Inside the outsourcing space